Figure 3
Figure 3. Compound deletion of RelB and cRel results in developmental block at the T1 stage. (A-C) FACS analysis of peripheral B-cell development in whole splenic extracts from wild-type, Relb−/−, cRel−/−, and Relb−/−cRel−/− mice. Identification of mature (B220+AA4.1−) and transitional B cells (B220+AA4.1+). Mature B cells (B220+AA4.1−) are further classified into FO B cells (CD21+IgM+) and mature MZ B cells (CD21highIgM+). Transitional B cells (B220+AA4.1+) are subdivided into T1 B cells (CD23−IgM+) and T2 B cells (CD23+IgM+). Scatter plots are graphical representation of FACS plots: wild-type (●), Relb−/− (▪), cRel−/− (▲), and Relb−/−cRel−/− (▼). (D) Histologic analysis of splenic sections taken from wild-type and Relb−/−cRel−/− mouse using hematoxylin and eosin stain (H&E). (E) In vivo analysis of mature B-cell development in double knockout mouse using immunofluorescence of frozen splenic sections stained with anti-CD3 fluorescein isothiocyanate, anti-B220 allophycocyanin, and anti-MOMA-1 Alexa Fluor 405. *P < .05; **P < .005; ***P < .001. Also see supplemental Figure 2.

Compound deletion of RelB and cRel results in developmental block at the T1 stage. (A-C) FACS analysis of peripheral B-cell development in whole splenic extracts from wild-type, Relb−/−, cRel−/−, and Relb−/−cRel−/− mice. Identification of mature (B220+AA4.1) and transitional B cells (B220+AA4.1+). Mature B cells (B220+AA4.1) are further classified into FO B cells (CD21+IgM+) and mature MZ B cells (CD21highIgM+). Transitional B cells (B220+AA4.1+) are subdivided into T1 B cells (CD23IgM+) and T2 B cells (CD23+IgM+). Scatter plots are graphical representation of FACS plots: wild-type (●), Relb−/− (▪), cRel−/− (▲), and Relb−/−cRel−/− (▼). (D) Histologic analysis of splenic sections taken from wild-type and Relb−/−cRel−/− mouse using hematoxylin and eosin stain (H&E). (E) In vivo analysis of mature B-cell development in double knockout mouse using immunofluorescence of frozen splenic sections stained with anti-CD3 fluorescein isothiocyanate, anti-B220 allophycocyanin, and anti-MOMA-1 Alexa Fluor 405. *P < .05; **P < .005; ***P < .001. Also see supplemental Figure 2.

Close Modal

or Create an Account

Close Modal
Close Modal